ATYR

Insider trade Purchase by SCHIMMEL PAUL

4d ago

News aTyr Pharma GAAP EPS of -$0.14 beats by $0.02

88d ago

SEC filing ATYR Posts $80.9M Cash, FDA Meeting Mid-April, Phase 3 EFZO-FIT Results, Phase 2 EFZO-CONNECT Enrollment 1H26, ATYR0101 Poster, NRP2/PLXNA1 Bispecific Publication

88d ago

Insider trade Sale by Nancy Denyes (General Counsel)

104d ago

Insider trade Sale by Jill Marie Broadfoot (Chief Financial Officer)

104d ago

Insider trade Sale by Sanjay Shukla (President and CEO)

104d ago

News E.F. Hutton Serves as Exclusive M&A Advisor to Smartkem on Proposed Acquisition of Carbonium Core, Inc.

117d ago

News aTyr Pharma to meet FDA in April to discuss lead asset

119d ago

News SelectQuote (SLQT) Faces Investor Lawsuit After DOJ Steps into Medicare Sales Probe – Hagens Berman

153d ago

News DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

153d ago

News ROSEN, A RANKED AND LEADING LAW FIRM, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR

153d ago

News INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in aTyr Pharma, Inc. of Class Action Lawsuit and Upcoming Deadlines - ATYR

153d ago

News ATYR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

153d ago

News Deadline Alert: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

153d ago

News MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

153d ago

News ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR

153d ago

News ATYR DEADLINE MONDAY: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages aTyr Pharma, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important December 8 Deadline in Securities Class Action - ATYR

153d ago

News ATYR CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds aTyr Investors to Contact the Firm Before December 8th Regarding Their Rights

153d ago

News ATYR Lawsuit: Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure

153d ago

Scanner Unusual volume (z=4.7)

160d ago

Scanner Unusual volume (z=4.9)

162d ago

Scanner Unusual volume (z=4.9)

163d ago

Scanner Unusual volume (z=4.9)

164d ago